IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,550,729 | -9.5% | 161,031 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,713,370 | +1.1% | 161,031 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,694,046 | -32.4% | 161,031 | -20.4% | 0.00% | 0.0% |
| Q4 2022 | $2,505,593 | +19.7% | 202,227 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $2,094,000 | -20.4% | 202,088 | -11.5% | 0.00% | 0.0% |
| Q2 2022 | $2,632,000 | -10.3% | 228,300 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $2,934,000 | +4.2% | 233,221 | -3.4% | 0.00% | 0.0% |
| Q4 2021 | $2,816,000 | -28.1% | 241,521 | -19.4% | 0.00% | -50.0% |
| Q3 2021 | $3,916,000 | +24.0% | 299,825 | +22.2% | 0.00% | +100.0% |
| Q2 2021 | $3,157,000 | +25.4% | 245,321 | +8.9% | 0.00% | 0.0% |
| Q1 2021 | $2,518,000 | -28.1% | 225,221 | -26.8% | 0.00% | -50.0% |
| Q4 2020 | $3,503,000 | +47.4% | 307,531 | +16.4% | 0.00% | +100.0% |
| Q3 2020 | $2,376,000 | -14.7% | 264,121 | -2.2% | 0.00% | -50.0% |
| Q2 2020 | $2,787,000 | +13.3% | 270,021 | +10.8% | 0.00% | 0.0% |
| Q1 2020 | $2,460,000 | -22.7% | 243,760 | +2.0% | 0.00% | 0.0% |
| Q4 2019 | $3,181,000 | +55.1% | 238,960 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $2,051,000 | -21.5% | 238,960 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $2,614,000 | -4.6% | 238,960 | +18.0% | 0.00% | 0.0% |
| Q1 2019 | $2,741,000 | +30.6% | 202,560 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,099,000 | -43.9% | 202,560 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,739,000 | -3.5% | 202,560 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $3,873,000 | +23.9% | 202,560 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $3,126,000 | +3.0% | 202,560 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,036,000 | -6.4% | 202,560 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $3,243,000 | -25.5% | 205,660 | -10.8% | 0.00% | -33.3% |
| Q2 2017 | $4,355,000 | -19.9% | 230,660 | -27.7% | 0.00% | -25.0% |
| Q1 2017 | $5,439,000 | -12.6% | 318,840 | -21.6% | 0.00% | -20.0% |
| Q4 2016 | $6,220,000 | +75.1% | 406,770 | +81.9% | 0.01% | +66.7% |
| Q3 2016 | $3,552,000 | +21.5% | 223,660 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,924,000 | +28.4% | 223,660 | +7.4% | 0.00% | +50.0% |
| Q1 2016 | $2,277,000 | -5.6% | 208,160 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $2,413,000 | +11.2% | 208,160 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,169,000 | -13.7% | 208,160 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,513,000 | -24.6% | 208,400 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $3,334,000 | +4.4% | 208,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $3,193,000 | +18.3% | 208,400 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $2,700,000 | -15.5% | 208,400 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $3,195,000 | +33.4% | 208,400 | +7.2% | 0.00% | +50.0% |
| Q1 2014 | $2,395,000 | +22.2% | 194,402 | +15.2% | 0.00% | 0.0% |
| Q4 2013 | $1,960,000 | -7.1% | 168,800 | -5.2% | 0.00% | 0.0% |
| Q3 2013 | $2,110,000 | +19.8% | 178,027 | +0.6% | 0.00% | 0.0% |
| Q2 2013 | $1,761,000 | – | 177,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |